F15.21 - Other stimulant dependence, in remission
- Applicable to Other stimulant dependence, in remission
- The 2025 edition of ICD10-CM F15.21 became effective on October 1, 2024.
- This is the American ICD10-CM version of F15.21 - other international versions of ICD10 F15.21 may differ.
- F15.21 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Inclusion terms help to clarify and specify the conditions or diseases covered by a particular ICD-10-CM code.
Inclusion Term:
- Amphetamine type substance use disorder, moderate, in early remission
- Amphetamine type substance use disorder, moderate, in sustained remission
- Amphetamine type substance use disorder, severe, in early remission
- Amphetamine type substance use disorder, severe, in sustained remission
- Other or unspecified stimulant use disorder, moderate, in early remission
- Other or unspecified stimulant use disorder, moderate, in sustained remission
- Other or unspecified stimulant use disorder, severe, in early remission
- Other or unspecified stimulant use disorder, severe, in sustained remission
Billable/Specific Code
The following codes above F15.21 contain annotation back-references that may be applicable to F15.21:
- Chapter: F01-F99 - Mental, Behavioral and Neurodevelopmental disorders
- Section: F10-F19 - Mental and behavioral disorders due to psychoactive substance use
- Category: F15 - Other stimulant related disorders
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com